Timor Leste

in page functions
[French]
Timor Leste
Total population (2017) 1,237,250
Birth cohort (2017) 44,048
Surviving Infants (surviving to 1 year per year, 2017) 42,368
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 45/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 53/1000
World Bank Index, IDA (2015) 3.02
Gross Nation Income (per capita US$, 2015) 2,180
Co-financing group (2018) Fully self-financing
No. of districts/territories (2016) 13

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Timor Leste

Type of support

Approvals

2001-2022 (US$)
(28 Mar 2018)

Commitments

2001-2022 (US$)
(28 Mar 2018)

Disbursements

2000-2018 (US$)
(28 Mar 2018)

% Disbursed

(28 Mar 2018)
2012 2013 2014 2015 2016 2017 2018
Total $5,930,221 $5,930,221 $5,012,565
Graduation grant (GG) $1,476,888 $1,476,888 $1,476,888 100%
Health system strengthening (HSS 1) $3,071,667 $3,071,667 $2,211,459 72%
Injection Safety Devices (NVS) $4,000 $4,000 $6,183 155%
IPV (NVS) $314,380 $314,380 $222,680 71%
Penta (NVS) $863,286 $863,286 $895,355 104%
Vaccine Introduction Grant (VIG) $200,000 $200,000 $200,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Timor Leste DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 95%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2008) 68.60%
Household survey: DTP3 coverage for female (2008) 64.10%
Household survey: Last DTP3 survey (2008) 66%
% districts achieving > 80% DTP3 coverage (2016) 100%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 78%

Breakdown of support

Non-vaccine support Vaccine support
78% 22%
$3,888,347 $1,124,218

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Timor Leste

30 November 2017

Gavi Board Dec 2017 - Nasala village visit

Millions of children set to be protected against typhoid fever

Gavi Board approves US$ 85 million funding window for 2019-2020 to support the introduction of typhoid conjugate vaccine in developing countries.

09 September 2017

Twinning Sri Lanka and Timor Leste 1

'Twinning' is winning: landmark Sri Lanka/Timor-Leste immunisation agreement

Sri Lanka to share best practices to help Timor-Leste transition out of Gavi support.

02 December 2016

Timor-Leste countryside

Making vaccines work in Timor-Leste: a small country with a big future

By Anuradha Gupta, Deputy CEO of Gavi, the Vaccine Alliance.

close icon

modal window here